Release Date: 04/06/15 09:57 Summary: Research Agreement signed with University of Uruguay Price Sensitive: Yes Download Document 475.4KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%